Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2017-000227-27Phase 4Completed
Phase 4, randomised, double-blind trial of dexamethasone in breast cancer (2 arms), sponsored by Eske Kvanner Aasvang. Primary endpoint: Proportion of patients transferred to postanesthesia care unit post surgery. Started Jan 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2017-000227-27.